
April 4 (Reuters) - Sarepta Therapeutics Inc SRPT.O:
SAREPTA THERAPEUTICS PROVIDES UPDATE ON ELEVIDYS
SAREPTA THERAPEUTICS: STUDIES AFFECTED BY TEMPORARY HALT ARE STUDY SRP-9001-302 (ENVOL), STUDY SRP-9001-303 (ENVISION), STUDY SRP-9001-104
SAREPTA THERAPEUTICS: CO, ROCHE WILL SUBMIT INFORMATION IN RESPONSE TO TEMPORARY HALT WITHIN WEEK
SAREPTA THERAPEUTICS INC -DO NOT ANTICIPATE A MATERIAL IMPACT ON TIMELINE FOR SRP-9001-302, SRP-9001-303, SRP-9001-104 STUDIES